Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 28, 2016; 22(40): 8967-8977
Published online Oct 28, 2016. doi: 10.3748/wjg.v22.i40.8967
Figure 5
Figure 5 Cumulative survival rates of control and deferasirox-treated mice in a murine hepatocellular carcinoma model. Deferasirox (DFX)-treated mice showed significantly higher survival rate than control mice (P < 0.01).